Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3704200
Author(s) Moss, Darren Michael; Marzolini, Catia; Rajoli, Rajith K. R.; Siccardi, Marco
Author(s) at UniBasel Marzolini, Catia
Year 2015
Title Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies
Journal Expert Opinion on Drug Metabolism & Toxicology
Volume 11
Number 8
Pages / Article-Number 1203-17
Mesh terms Animals; Anti-Infective Agents, pharmacokinetics; Computer Simulation; Drug Design; Drug Interactions; Humans; Models, Biological; Models, Theoretical; Tissue Distribution
Abstract The pharmacokinetic properties of anti-infective drugs are a determinant part of treatment success. Pathogen replication is inhibited if adequate drug levels are achieved in target sites, whereas excessive drug concentrations linked to toxicity are to be avoided. Anti-infective distribution can be predicted by integrating in vitro drug properties and mathematical descriptions of human anatomy in physiologically based pharmacokinetic models. This method reduces the need for animal and human studies and is used increasingly in drug development and simulation of clinical scenario such as, for instance, drug-drug interactions, dose optimization, novel formulations and pharmacokinetics in special populations.; We have assessed the relevance of physiologically based pharmacokinetic modeling in the anti-infective research field, giving an overview of mechanisms involved in model design and have suggested strategies for future applications of physiologically based pharmacokinetic models.; Physiologically based pharmacokinetic modeling provides a powerful tool in anti-infective optimization, and there is now no doubt that both industry and regulatory bodies have recognized the importance of this technology. It should be acknowledged, however, that major challenges remain to be addressed and that information detailing disease group physiology and anti-infective pharmacodynamics is required if a personalized medicine approach is to be achieved.
Publisher TAYLOR & FRANCIS LTD
ISSN/ISBN 1744-7607
URL https://www.ncbi.nlm.nih.gov/pubmed/25872900
edoc-URL https://edoc.unibas.ch/69514/
Full Text on edoc No
Digital Object Identifier DOI 10.1517/17425255.2015.1037278
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/25872900
ISI-Number WOS:000358976900003
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.445 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
24/04/2024